SCHEMBL29982301

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)N(C)C(=O)[C@H](C)N(Cl)C(C)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC

nearest known ligand 0.56

Predicted protein targets (top 3)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	15/20	0.56

▸	KISS1R	Q969F8	4/20	0.52

▸	CD47	Q08722	1/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29981789	0.92	IL23R (0.58)	IL23RKISS1RCD47
SCHEMBL29982283	0.85	KISS1R (0.62)	IL23RKISS1R
SCHEMBL30401709	0.85	KISS1R (0.62)	IL23RKISS1R
SCHEMBL30401759	0.84	KISS1R (0.61)	IL23RKISS1R
SCHEMBL29981974	0.83	KISS1R (0.59)	IL23RKISS1R
SCHEMBL29981946	0.83	KISS1R (0.59)	IL23RKISS1R
SCHEMBL29982442	0.82	KISS1R (0.54)	IL23RKISS1R
SCHEMBL29982290	0.82	KISS1R (0.54)	IL23RKISS1R
SCHEMBL30202389	0.80	KISS1R (0.53)	KISS1R
SCHEMBL30093011	0.80	IL23R (0.54)	IL23RKISS1RCD47

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230203098-A1	HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE	JCR PHARMACEUTICALS CO., LTD. (JP)	2023-06-29	—	—	US	disclosed
EP-4108676-A1	HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE	JCR Pharmaceuticals Co., Ltd. (JP)	2022-12-28	—	—	EP	disclosed
CN-115151556-A	Human transferrin receptor binding peptides	JCR制药股份有限公司	2022-10-04	—	—	CN	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20230203098-A1	HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE	TFRC, SLC3A2, SLC7A1	IL23R 1413/4885KISS1R 1171/4885CD47 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.